Cargando…
Hyperbaric Oxygen Therapy Improves Parkinson’s Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway
Hyperbaric oxygen therapy (HBOT) has been suggested as a potential adjunctive therapy for Parkinson’s disease (PD). PD is a neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). The aim of this study was to investigate t...
Autores principales: | Hsu, Hung-Te, Yang, Ya-Lan, Chang, Wan-Hsuan, Fang, Wei-Yu, Huang, Shu-Hung, Chou, Shah-Hwa, Lo, Yi-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138219/ https://www.ncbi.nlm.nih.gov/pubmed/35625589 http://dx.doi.org/10.3390/biom12050661 |
Ejemplares similares
-
Effects of Resveratrol and SIRT1 on PGC-1α Activity and Mitochondrial Biogenesis: A Reevaluation
por: Higashida, Kazuhiko, et al.
Publicado: (2013) -
Correction: Effects of Resveratrol and SIRT1 on PGC-1α Activity and Mitochondrial Biogenesis: A Reevaluation
por: Higashida, Kazuhiko, et al.
Publicado: (2014) -
SIRT1 facilitates hepatocellular carcinoma metastasis by promoting PGC-1α-mediated mitochondrial biogenesis
por: Li, Yuming, et al.
Publicado: (2016) -
miR449a/SIRT1/PGC-1α Is Necessary for Mitochondrial Biogenesis Induced by T-2 Toxin
por: Ma, Shijie, et al.
Publicado: (2018) -
Empagliflozin attenuates doxorubicin-induced cardiotoxicity by activating AMPK/SIRT-1/PGC-1α-mediated mitochondrial biogenesis
por: Chen, Meicong
Publicado: (2023)